Personalized medicine

Precision medicine often relies on population databases – but are they precise enough?

Could macular degeneration be diagnosed through blood plasma analysis?

Eleftherios P. Diamandis, Hold ’em for Life Chair in Prostate Cancer Biomarkers, University of Toronto.

We need to explain the context when using “grab bag” phrases in science and medicine

From being one of the first clinicians to voice doubts over Vioxx, to his latest book calling for a complete transformation of the patient–doctor relationship, Eric Topol has never been afraid to raise his head above the parapet.

In today’s highly competitive academic world, are we losing sight of the real goal of biomedical research in our rush to secure funding and embrace the latest technologies?

Sitting Down With… Julian Solway MD, Walter L. Palmer Distinguished Service Professor - Medicine and Pediatrics, Director - Institute for Translational Medicine, Dean for Translational Medicine, University of Chicago, USA.

The combination of genomic profiling and high-tech targeted drug delivery is opening up a new front in the fight against cancer.

Better understanding of human biology presents us with an opportunity to combat disease on two fronts – targeting individual variation on one hand and universal mechanisms on the other.